Topic
MHRA Approvals
Latest pieces
- MHRA publishes 2026–2030 plan to widen patient involvement in regulation
10 Nov 2026
- MHRA grants conditional approval to triheptanoin for rare inherited fatty acid disorders
3 Nov 2026
- MHRA extends Casgevy approval to children aged five and over with sickle cell disease and β-thalassaemia
2 Nov 2026
- MHRA introduces new antidepressant warnings on suicidal thoughts and persistent sexual dysfunction
19 Oct 2026
- NHS fast-tracks AI deployment across services in bid to tackle waiting lists
27 Sept 2026
- Medicare Advantage rate cuts reshape 2027 bids as plans retreat from rural markets
27 Sept 2026
- KKR completes Envision restructuring at $7.0bn, wiping out earlier equity
25 Sept 2026
- Hippocratic AI raises $175m Series B for clinical staffing agents
24 Sept 2026
- Lilly agrees $2.8bn AtaiBeckley acquisition in neuropsychiatry push
22 Sept 2026
- NHS Genomic Medicine Service widens whole-genome eligibility in paediatric oncology
20 Sept 2026
- UK Regulators Tighten Oversight on AI Medical Devices with New Guidance
5 Sept 2026
- Precision Medicine Sector Sees European Funding Surge Amidst Regulatory Harmonisation Hopes
2 Sept 2026
- Patient Data Sharing Initiative Launches Across England Pilot, Raising Privacy Questions
25 Aug 2026